Acteon’s mission is to enable dental and medical professionals to provide the most effective, convenient, and comfortable care to millions of patients every day.
Their vision is to become the innovator most trusted by dental and medical professionals worldwide for comprehensive clinical treatment solutions. This is one of the reasons why Acteon are excited to partner with Medit to access the I700 and I700 wireless intraoral scanners.
With many more practices making the move to digital, these scanners complement their imaging, surgical and prosthetic workflows and allow them to offer their customers a comprehensive solution.
X-Mind Prime is now one of the most well know CBCT units on the market. This extremely compact, space-saving device with its smart wall mounted system will never get in your way.
The affordable unit offers 56 2D panoramic and 3D CBCT programs as well as allowing the possibility to scan 3D objects.
Confidence and freedom
Coupled with AIS (Acteon Imaging Suite) software, treatment planning has never been so easy to do. This intuitive software guides users through each step of the process giving complete confidence and freedom to plan.
- Draw a panoramic curve
- Trace the mandibular canal and measure the distance between the upper canal boundary and the upper mandibular crestal bone
- Select the correct implant from the comprehensive library
- Complete the implant report in less than one minute
- You can also scan the patient appliance with the X-Mind Prime 3D scan objects feature and match it to the scan
- Create a surgical guide.
The 3D design app is available for those who wish to design a surgical guide. The STL file can be very easily exported to a lab or in house 3D printer.
By adding the I700 and I700W to their portfolio, Acteon can now offer the full digital imaging workflow and be competitive in this digitally driven industry.
The super-fast, accurate and lightweight scanners are the perfect partner to X-Mind Prime.
Contact Acteon on 0800 038 9840 or email [email protected] for more details.